Accelerated immunosenescence in SLE: current evidence and clinical translation
-
By
-
Qingshuang Li
-
Wei Zhang
-
Yulan Chen
-
Jing Du
-
June 17, 2026
-
Clinical Scorecard: Rapid Immune Aging in Systemic Lupus Erythematosus: Evidence and Clinical Implications
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Primarily young women with SLE, typically aged 15-45. |
| Care Setting | |
Key Highlights
- Cognitive impairment is a significant concern in SLE patients.
Guideline-Based Recommendations
Diagnosis
Management
- Monitor for age-related comorbidities in SLE patients.
- Assess cognitive health regularly.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Women of childbearing age with SLE.
Treatment exposure may influence immune aging and disease burden.
Clinical Best Practices
- Integrate assessment of immunosenescence in routine SLE management.
- Evaluate cardiovascular health, frailty, and cognitive function in SLE patients.
Related Resources & Content
